PharmaPoint: Hepatitis C Virus - Current and Future Players

Publisher Name :
Date: 31-May-2013
No. of pages: 64
Inquire Before Buying

Summary

GlobalData has released its pharma report, “PharmaPoint: Hepatitis C Virus - Current and Future Players”. The report is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing HCV Market. The report identifies and analyses the key companies shaping and driving the global HCV market. The report provides insight into the competitive HCV landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by GlobalData’s team of industry experts.

Scope


  • Investigation of current and future market competition for HCV

  • Competitor assessment

  • Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.

  • Strategic assessment of the HCV sector through market impact analysis, future market scenario and company analysis


Reasons to buy

  • Gain a high level view of the trends shaping and driving the HCV Market

  • Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.

  • Create an effective counter-strategy to gain a competitive advantage against those currently in the market

  • What’s the next big thing in the global HCV market landscape? Identify, understand and capitalize

PharmaPoint: Hepatitis C Virus - Current and Future Players

Table Of Contents

1 Table of Contents 5
1.1 List of Tables 7
1.2 List of Figures 8

2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 9
2.3 Upcoming Related Reports 11

3 Market Outlook 12
3.1 Global Markets 12
3.1.1 Forecast 12
3.1.2 Drivers and Barriers – Global Issues 16

4 Current and Future Players 21
4.1 Overview 21
4.2 Trends in Corporate Strategy 23
4.3 Company Profiles 24
4.3.1 Merck 24
4.3.2 Roche 26
4.3.3 Vertex 28
4.3.4 Janssen 29
4.3.5 Gilead 31
4.3.6 AbbVie 34
4.3.7 Bristol-Myers Squibb 36
4.3.8 Boehringer Ingelheim 38
4.4 Additional Companies with Promising Drugs 40
4.4.1 Mitsubishi Tanabe 40
4.4.2 GlaxoSmithKline 41
4.4.3 Achillion 41
4.4.4 Scynexis 42
4.4.5 Idenix 43
4.4.6 Presidio 44

5 Appendix 45
5.1 Bibliography 45
5.2 Abbreviations 48
5.3 Methodology 49
5.4 Forecasting Methodology 49
5.4.1 Percent Drug-Treated Patients 49
5.4.2 Patient Warehousing 50
5.4.3 Drugs Included in Each Therapeutic Class 50
5.4.4 Launch and Patent Expiry Dates 51
5.4.5 General Pricing Assumptions 52
5.4.6 Individual Drug Assumptions 52
5.4.7 Generic Erosion 55
5.4.8 Selection of Pipeline Agents 55
5.4.9 Pricing of Pipeline Agents 56
5.5 Physicians and Specialists Included in this Study 59
5.6 Survey of Prescribing Physicians 61
5.7 About the Authors 62
5.7.1 Author 62
5.7.2 Epidemiologist 62
5.7.3 Global Head of Healthcare 63
5.8 About GlobalData 64
5.9 Contact Us 64
5.10 Disclaimer 64

List Of Tables

Table 1: Global Sales Forecasts ($m) for HCV, 2012–2022 14
Table 2: HCV Market – Drivers and Barriers, 2013 16
Table 3: Key Companies in the HCV Market, 2012 22
Table 4: Merck’s HCV Portfolio Assessment, 2012 25
Table 5: Merck SWOT Analysis, 2012 25
Table 6: Roche’s HCV Portfolio Assessment, 2012 27
Table 7: Roche SWOT Analysis, 2012 27
Table 8: Vertex’s HCV Portfolio Assessment, 2012 28
Table 9: Vertex SWOT Analysis, 2012 29
Table 10: Janssen’s HCV Portfolio Assessment, 2012 30
Table 11: Janssen SWOT Analysis, 2012 31
Table 12: Gilead’s HCV Portfolio Assessment, 2012 33
Table 13: Gilead SWOT Analysis, 2012 33
Table 14: AbbVie’s HCV Portfolio Assessment, 2012 35
Table 15: AbbVie SWOT Analysis, 2012 35
Table 16: Bristol-Myers Squibb’s HCV Portfolio Assessment, 2012 37
Table 17: Bristol-Myers Squibb SWOT Analysis, 2012 37
Table 18: Boehringer Ingelheim’s HCV Portfolio Assessment, 2012 39
Table 19: Boehringer Ingelheim SWOT Analysis, 2012 39
Table 20: Mitsubishi Tanabe’s HCV Portfolio Assessment, 2012 40
Table 21: GlaxoSmithKline’s HCV Portfolio Assessment, 2012 41
Table 22: Achillion’s HCV Portfolio Assessment, 2012 42
Table 23: Scynexis’ HCV Portfolio Assessment, 2012 42
Table 24: Idenix’s HCV Portfolio Assessment, 2012 43
Table 25: Presidio’s HCV Portfolio Assessment, 2012 44
Table 26: Key Launch Dates 51
Table 27: Key Patent Expiries 51
Table 28: Physicians Surveyed, By Country 61

List of Figures

Figure 1: Global Sales for HCV Therapeutics by Region, 2012–2022 15
Figure 2: Company Portfolio Gap Analysis in HCV, 2012–2022 22

  • Packaging Sector Driven By Innovation
    The financial development in numerous emerging nations has significantly influenced the progress of quite a lot of sectors, the packaging industry being one of them. The swell in transport undertakings outfitting to a substantial number of industries such as manufacturing, consumer goods, food and beverages, and others rest essentially on sturdy and resilient packaging solutions [...]
  • Global Eyewear Market To Gain From Increased Demand For Disposable Contact Lenses
    The global eyewear market was worth US$ 102.66 billion in 2015 and is predictable to reach US$ 184.03 billion by 2024. The rising population and upsurge in the number of optical disorders are likely to propel the industry in the near future. Moreover, the increasing cognizance amongst people as regards to the prominence of eye [...]
  • Global mHealth Market To Become A Multi-Billion Dollar Industry By 2020
    The mHealth market is in its embryonic stage and is projected to produce substantial profits with amassed awareness level and encouraging regulatory guidelines particular to the quality and practicality of mobile-based medical devices. The global mHealth market is projected to touch US$ 49.12 billion by 2020 rising at a CAGR of 47.6% from 2013 to 2020. Monitoring services [...]
  • Efficacy of Stand-alone Power Sources Drive The Global Distributed Energy Generation Market
    The global market for distributed energy generation is expected to magnify at a momentous CAGR of 11.4% between 2016 and 2020. The small-scale generation of electricity, oscillating from a few kilowatts to multitudes of megawatts, is denoted as distributed energy generation. In this process, power is usually produced using renewable resources or by generators during consumption. [...]
  • Global Organic Food Market Makes A Mark in Developed Economies
    Buyers throughout the world are becoming more and more health cognizant, which has occasioned in an alteration in their palates and inclinations. The global organic food market was worth US$88.1 billion in 2015 is anticipated to record a CAGR of over 16% between 2015 and 2020. Amongst the various different food products available, the fruits [...]
  • United States Hepatitis Drugs Market Report 2017
    Published: 10-Jan-2017        Price: US 3800 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Hepatitis Drugs Revenue, means the sales value of Hepatitis Drugs This report studies sales (consumption) of Hepatitis Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering - F. Hoffmann-La Roche - Gilead Sciences - GlaxoSmithKline - Johnson & Johnson - Merck - Novartis - Vertex Pharmaceuticals - Ab......
  • Global Hepatitis Drugs Market Professional Survey Report 2017
    Published: 05-Jan-2017        Price: US 3500 Onwards        Pages: 124
    Notes: Production, means the output of Hepatitis Drugs Revenue, means the sales value of Hepatitis Drugs This report studies Hepatitis Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market sh......
  • Hepatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
    Published: 01-Jan-2017        Price: US 2000 Onwards        Pages: 100
    DelveInsight's Report, "Hepatitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016", provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Hepatitis Report is to understand the market and pipeline status of the drugs around the Hepatitis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline ......
  • Telavic -Drug Insights, 2017
    Published: 01-Jan-2017        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Telavic- Drug Insights, 2017" highlights the Telavic marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Telavic covering the total sales estimation and also provides the Telavic sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Telavic, patents information and exclus......
  • Victrelis -Drug Insights, 2017
    Published: 01-Jan-2017        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Victrelis- Drug Insights, 2017" highlights the Victrelis marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Victrelis covering the total sales estimation and also provides the Victrelis sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Victrelis, patents information ......
  • ViraferonPeg -Drug Insights, 2017
    Published: 01-Jan-2017        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "ViraferonPeg- Drug Insights, 2017" highlights the ViraferonPeg marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the ViraferonPeg covering the total sales estimation and also provides the ViraferonPeg sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of ViraferonPeg, paten......
  • Viread -Drug Insights, 2017
    Published: 01-Jan-2017        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Viread- Drug Insights, 2017" highlights the Viread marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Viread covering the total sales estimation and also provides the Viread sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Viread, patents information and exclusivity......
  • Hepatitis-API Insights, 2017
    Published: 01-Jan-2017        Price: US 1250 Onwards        Pages: 60
    The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority of the APIs and intermediates produced in the world currently. The USFDA and EMA have......
  • Zeffix -Drug Insights, 2017
    Published: 01-Jan-2017        Price: US 1000 Onwards        Pages: 35
    DelveInsight Drug Report, "Zeffix- Drug Insights, 2017" highlights the Zeffix marketed details, pipeline status and the Global API Manufacturers along with the location. The DelveInsight's report covers the Global Market Assessment of the Zeffix covering the total sales estimation and also provides the Zeffix sales performance during the historical period and forecast period to 2018. DelveInsight's Report also covers the detailed clinical assessment of Zeffix, patents information and exclusivity......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs